Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Grupo Hospital de Madrid
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of stage IV colorectal adenocarcinoma.
Age ≥ 18 years .
Measurable disease by RECIST criteria.
Life expectancy ≥ 6 months.
Candidate to receive treatment with first-line chemotherapy.
Availability of tumor tissue.
You may not be if
Patients who have received prior treatment with first-line chemotherapy for metastatic disease.
Patients in whom there is contraindication to the administration of either drug used in the study: capecitabine, irinotecan, oxaliplatin or Bev.
Patients receiving anticoagulant oral treatment.
Patient with diagnosis of other malignancies within 5 years prior to diagnosis except basal cell carcinoma or cervical carcinoma · in situ. · The inclusion of patients with malignant disease diagnosed more than 5 years ago without recurrence in the previous 3 years will be analyzed individually
Patients with bone disease as the only manifestation of the disease.
Clareo Health | Angiogenic Switch in Patients With Colorectal Cancer
